- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05564351
Ear Plug and Eye Mask Use on Sleep Quality in Intensive Care Patients
September 28, 2022 updated by: AYSUN KAZAK, Mersin University
Evaluation of the Effect of Ear Plug and Eye Mask Use on Sleep Quality in Intensive Care patıents: Randomized Controlled Study
This study was conducted as a pre-test and post-test randomized controlled single center study to evaluate the effect of ear plugs and eye mask application on sleep quality in patients hospitalized in the intensive care unit.
120 patients who received inpatient treatment in Siirt State Hospital general intensive care unit constitute the sample of the study.
The sample consist of four groups: ear plug group (n=30), eye mask group (n=30), earplug-eye mask group (n=30) and control group (n=30).
Data were collected using the "Patient Identification Form, Glasgow Coma Skale, Visual Analog Scale, Richards-Campbell Sleep Questionnaire (RCSQ), ear plug and eye mask".
As a preliminary test, RCSQ was applied in the morning of the second day after the first night sleep of the patients.
Then, according to the group they were assigned to, the patients were allowed to sleep by applying only ear plug, eye mask only and simultaneous ear plug-eye mask between 22:00-06:00.
As a final test, RCSQ was readministered to patients on the morning of the third day after the second night's sleep.
During the analysis of the data, frequency, number, mean, Student t test and/or Mann- Whitney U test, ANOVA and/or Kruskal- Wallis test, t test or Wilcoxon Sign test, chi-square test were used.
Study Overview
Study Type
Interventional
Enrollment (Actual)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Siirt, Turkey
- Siirt State Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Being 18 years or older
- Being literate
- No hearing impairment
- Ability to communicate verbally
- Receiving inpatient treatment in the GICU for at least 3 days
- Have 15 Glasgow Coma Scale (GCS) scores (Minimum scores will be as follows. 3 points from eye response; 5 points from motor response; 2 points from verbal response)
- Agreeing to participate in the research
Exclusion Criteria:
Having a Visual Analog Scale (VAS) score above 7
- Using sleeping pills or sedative drugs
- Being treated with a diagnosis of sleep disorder
- Being on mechanical ventilation
- Having an active ear or eye infection
- Having a diagnosed psychiatric illness
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
|
|
|
Experimental: Ear plug group
|
black eye mask and silicon ear plug
|
|
Experimental: Eye mask group
|
black eye mask and silicon ear plug
|
|
Experimental: Eye mask+Ear plug group
|
black eye mask and silicon ear plug
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Richards Campbell Sleep Scale
Time Frame: Three day
|
RCSS is a six-item scale that evaluates the depth of night sleep, the time to fall asleep, the frequency of waking, the time to stay awake when awakened, the quality of sleep, and the noise level in the environment.
|
Three day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale
Time Frame: Three day
|
The scale developed by Price et al. in 1983 measures the severity of the patient's pain.
|
Three day
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glasgow Coma Scale
Time Frame: Three day
|
The GCS was developed in Scotland/Glasgow in 1974 and is an international measurement tool that reflects the patient's state of consciousness.
In the GCS, scoring is done in three separate sections: eye opening, verbal and motor response.
|
Three day
|
|
Patient Information Form
Time Frame: one day
|
In this form, which was created by the researchers by scanning the literature; There are 13 questions in total, including patients' age, gender, marital status, education level, medical diagnosis, chronic diseases, drugs used, length of hospital stay and sleep habits, etc.
|
one day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 10, 2021
Primary Completion (Actual)
May 30, 2022
Study Completion (Actual)
June 1, 2022
Study Registration Dates
First Submitted
September 28, 2022
First Submitted That Met QC Criteria
September 28, 2022
First Posted (Actual)
October 3, 2022
Study Record Updates
Last Update Posted (Actual)
October 3, 2022
Last Update Submitted That Met QC Criteria
September 28, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- "A.KAZAK33-H.TOPALI31"!
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Quality
-
PrecisionBiotics Group Ltd.Nottingham Trent University; Atlantia Food Clinical Trials Ltd.CompletedSubjective Sleep Quality | Objective Sleep QualityIreland
-
Brain Electrophysiology Laboratory CompanyRecruiting
-
University GhentEuropean CommissionCompleted
-
Northumbria UniversityCompletedSleep | Mood | Poor Quality Sleep | Good Sleep HabitUnited Kingdom
-
Nutrition Institute, SloveniaValens Int. d.o.o., Slovenija; Faculty of Pharmacy, University of Ljubljana... and other collaboratorsRecruitingSleep Quality | Sleep Onset LatencySlovenia
-
Bezmialem Vakif UniversityNot yet recruiting
-
West Virginia UniversityCompletedSleep QualityUnited States
-
Osmaniye Korkut Ata UniversityNot yet recruiting
-
West Virginia UniversityCompletedSleep QualityUnited States
-
West Virginia UniversityCompletedSleep QualityUnited States
Clinical Trials on eye mask and ear plug
-
Assiut UniversityUnknown
-
Assiut UniversityCompleted
-
Maharishi Markendeswar University (Deemed to be...Completed
-
University of Texas Southwestern Medical CenterCompleted
-
The University of Texas Health Science Center,...Not yet recruiting
-
Emory UniversityCenters for Disease Control and PreventionCompleted
-
Melek YÜKSELEge UniversityNot yet recruitingAnxiety Physiological Stress Responses ,Fiberoptic Bronchoscopy, Sensory IsolationTurkey (Türkiye)
-
Necmettin Erbakan UniversityNot yet recruitingCardiovascular Surgical ProceduresTurkey
-
Osmaniye Korkut Ata UniversityCompletedSleep Quality | Vital SignsTurkey
-
Singapore General HospitalCompletedSleep | Critical Care | Major Abdominal SurgerySingapore